Third COVID-19 vaccine dose effective and safe for transplant recipients: study
Researchers say $2.1 million will back efforts at determining vaccine effectiveness among people with blo...
Read moreResearchers say $2.1 million will back efforts at determining vaccine effectiveness among people with blo...
Read moreThe authors concluded that vaccination with Pfizer / BioMtech “after 75 or more years of age does not see...
Read moreBeginning August 9, fully vaccinated citizens and permanent residents of the United States currently resi...
Read moreHere's what you should know before booking your long-awaited vacation. Find out more here.
Read moreThe race to develop vaccines for COVID-19 marks the beginning of a new chapter in medicine: one where we...
Read moreCanada is planning to contribute up to 100 million doses of COVID-19 vaccines to developing countries, in...
Read moreJoin our community and sign up for our newsletter.